Literature DB >> 34374838

Validation of computed tomography angiography as a complementary test in the assessment of renal artery stenosis: a comparison with digital subtraction angiography.

Anilawan S Fleury1, Rachelle E Durand2, Anne Marie Cahill1, Xiaowei Zhu1, Kevin E Meyers3, Hansel J Otero4.   

Abstract

BACKGROUND: Renal artery stenosis is an important cause of hypertension in children, accounting for 5-10% of cases. When suspected, noninvasive imaging options include ultrasound (US), computed tomography (CT) angiography and magnetic resonance (MR) angiography. However, digital subtraction angiography (DSA) remains the gold standard.
OBJECTIVE: To investigate the accuracy and inter-reader reliability of CT angiography in children with suspected renal artery stenosis.
MATERIALS AND METHODS: This is a retrospective study of patients suspected of having renal artery stenosis evaluated by both CT angiography and DSA between 2008 and 2019 at a tertiary pediatric hospital. Only children who underwent CT angiography within 6 months before DSA were included. CT angiography studies were individually reviewed by two pediatric radiologists, blinded to clinical data, other studies and each other's evaluation, to determine the presence of stenosis at the main renal artery and 2nd- and 3rd-order branches. The sensitivity, specificity and accuracy were calculated using DSA as the reference. The effective radiation dose for CT angiography and DSA was also calculated. Kappa statistics were used to assess inter-reader agreement.
RESULTS: Seventy-four renal units were evaluated (18 girls, 19 boys). The patients' median age was 8 years (range: 1-21 years). Overall, CT angiography was effective in detecting renal artery stenosis with a sensitivity of 85.7%, specificity of 91.5% and accuracy of 88.9%. There was moderate inter-reader agreement at the main renal artery level (k=0.73) and almost perfect inter-reader agreement at the 2nd/3rd order (k=0.98). However, the sensitivity at the 2nd- and 3rd-order level was lower (14.3%). CT angiography provided excellent negative predictive value for evaluating renal artery stenosis at the main renal artery level (90.1%) and at the 2nd- or 3rd-order branches (82.7%). The median effective dose of CT angiography studies was 2.2 mSv (range: 0.6-6.3) while the effective dose of DSA was 13.7 mSv.
CONCLUSION: CT angiography has high sensitivity and specificity at the main renal artery level with a lower radiation dose than previously assumed. Therefore, it can be used as a diagnostic tool in patients with low to medium risk of renal artery stenosis, and as a screening and treatment planning tool in patients at high risk.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Children; Computed tomography angiography; Digital subtraction angiography; Hypertension; Renal artery; Stenosis

Mesh:

Year:  2021        PMID: 34374838     DOI: 10.1007/s00247-021-05145-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  45 in total

1.  Angioplasty for renovascular hypertension in children: 20-year experience.

Authors:  Rukshana Shroff; Derek J Roebuck; Isky Gordon; Roger Davies; Suzanne Stephens; Stephen Marks; Mark Chan; Maria Barkovics; Clare A McLaren; Vanita Shah; Michael J Dillon; Kjell Tullus
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

Review 2.  Percutaneous transluminal angioplasty of renal artery stenosis in children.

Authors:  J V Courtel; B Soto; P Niaudet; M F Gagnadoux; M Carteret; J F Quignodon; F Brunelle
Journal:  Pediatr Radiol       Date:  1998-01

3.  Postoperative imaging for detection of recurrent arteriovenous malformations in children.

Authors:  Peter F Morgenstern; Caitlin E Hoffman; Gary Kocharian; Ranjodh Singh; Philip E Stieg; Mark M Souweidane
Journal:  J Neurosurg Pediatr       Date:  2015-10-30       Impact factor: 2.375

4.  A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis.

Authors:  H Eklöf; H Ahlström; A Magnusson; L-G Andersson; B Andrén; A Hägg; D Bergqvist; R Nyman
Journal:  Acta Radiol       Date:  2006-10       Impact factor: 1.990

5.  Evaluation and long-term outcome of pediatric renovascular hypertension.

Authors:  S J McTaggart; S Gulati; R G Walker; H R Powell; C L Jones; S Gelati
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

6.  Malignant hypertension in children in India.

Authors:  P Kumar; P Arora; V Kher; P K Rai; S Gulati; S S Baijal; S Kumar
Journal:  Nephrol Dial Transplant       Date:  1996-07       Impact factor: 5.992

7.  Spectrum of renal findings in pediatric fibromuscular dysplasia and neurofibromatosis type 1.

Authors:  Abhay Srinivasan; Ganesh Krishnamurthy; Lucia Fontalvo-Herazo; Els Nijs; Kevin Meyers; Bernard Kaplan; Anne-Marie Cahill
Journal:  Pediatr Radiol       Date:  2010-10-16

Review 8.  Renovascular hypertension in children.

Authors:  Kjell Tullus; Eileen Brennan; George Hamilton; Rozanne Lord; Clare A McLaren; Stephen D Marks; Derek J Roebuck
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

9.  Reno-vascular hypertension in childhood: a nationwide survey.

Authors:  Aysun K Bayazit; Fatos Yalcinkaya; Nilgun Cakar; Ali Duzova; Zelal Bircan; Aysin Bakkaloglu; Nur Canpolat; Nazl Kara; Aydan Sirin; Mesiha Ekim; Ayse Oner; Sema Akman; Sevgi Mir; Esra Baskin; Hakan M Poyrazoglu; Aytul Noyan; Ipek Akil; Sevcan Bakkaloglu; Alper Soylu
Journal:  Pediatr Nephrol       Date:  2007-05-30       Impact factor: 3.714

10.  Imaging studies in pediatric fibromuscular dysplasia (FMD): a single-center experience.

Authors:  Robert Louis; Daniella Levy-Erez; Anne Marie Cahill; Kevin E Meyers
Journal:  Pediatr Nephrol       Date:  2018-06-04       Impact factor: 3.714

View more
  1 in total

1.  Deep Learning-Based Digital Subtraction Angiography Characteristics in Nursing of Maintenance Hemodialysis Patients.

Authors:  Jinyan Mi
Journal:  Contrast Media Mol Imaging       Date:  2022-08-27       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.